Citizens Reiterates Market Perform on enGene Therapeuticsto Market Perform

Benzinga Newsdesk Sep 9, 2026 1 month ago

Analyst RatingsNewsReiteration

Citizens analyst Silvan Turkcan reiterates enGene Therapeutics (NASDAQ:ENGN) from Market Perform to Market Perform.